Previous 10 | Next 10 |
AIkido Pharma Provides Update on Share Repurchase Program PR Newswire NEW YORK , Sept. 30, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) ("AIkido" or the "Company") today provided an update on the $3 million share repurchase program (the "Sha...
Dominari Financial, the financial services subsidiary of AIkido Pharma ( NASDAQ: AIKI ) agrees to acquire a broker-dealer firm. It is Dominari's first acquisition since launching in June. Dominari Financial was formed with the intention of acquiring revenue generat...
Dominari Financial, Inc. Executes Definitive Agreement to Buy Broker-Dealer PR Newswire Acquisition Will Accelerate Growth Strategy NEW YORK , Sept. 9, 2022 /PRNewswire/ -- Dominari Financial, Inc., the financial services subsidiary of AIkido Pharma I...
AIkido Pharma Confirms Receipt of Unsolicited Offer PR Newswire NEW YORK , Aug. 10, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today confirms that on August 9, 2022 , the Company received an unsolicited offer fr...
Alkido Pharma's ( NASDAQ: AIKI ) significant stockholder Shalom Auerbach, who owns ~3.8% of its stock, announced that he has sent a letter proposing to acquire the company for $8/share in cash. This proposal to buy AIKI represents a 31% premium to the company’s most...
Proposal for All-Cash Transaction Represents a 31% Premium to AIKI’s Most Recent Closing Price Urges the Board to Immediately Enter into Good Faith Discussions with the Investor and Work to Deliver a Meaningful Premium to AIKI’s Stockholders NEW YORK, Aug. 09...
AIkido Pharma, Inc. Hires Carlos Aldavero to Lead Financial Services Subsidiary PR Newswire Morgan Stanley Executive Joins Dominari Financial, Inc. on July 22, 2022 NEW YORK , July 21, 2022 /PRNewswire/ -- Anthony Hayes, CEO of AIkido Pha...
AIkido Pharma (NASDAQ:AIKI) has regained compliance with the Nasdaq's requirements when the closing bid price for the company's common stock was at or above $1.00 for 10 consecutive business days. On June 23, 2022, the company received a letter Nasdaq for non-compliance with minimum bid ...
AIkido Inc. Announces the Formation of a New Financial Services Subsidiary PR Newswire Long-Range Strategy Seeks Diversification into Three Key Industries NEW YORK , June 24, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Com...
Up 1,845.8% to $5.74, AIkido Pharma Inc. (NSC:AIKI), is one of today's notable movers. In the past 52 weeks, shares of AIkido Pharma Inc. have traded between a low of $4.30 and a high of $20.57 and is now at $5.74, which is 33% above that low price. Receive IBN Spotlights - "Bite Size"...
News, Short Squeeze, Breakout and More Instantly...
AIkido Pharma Inc. Company Name:
AIKI Stock Symbol:
NASDAQ Market:
AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH) PR Newswire NEW YORK , Dec. 22, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) (the "Company") today announced that it has changed its name from AI...
AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes PR Newswire Leading Advanced Materials Company Now Listed on NASDAQ under the symbol, ASPI NEW YORK , Nov. 28, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) (...
AIkido Share Repurchase Continues PR Newswire NEW YORK , Oct. 6, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update on the Company's share repurchase program (the "Share Repurchase Program") authori...